Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075390 | SCV001241012 | likely pathogenic | Retinal dystrophy | 2018-07-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001386010 | SCV001586083 | pathogenic | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg440*) in the TULP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TULP1 are known to be pathogenic (PMID: 8606774, 10549638, 15024725, 18055821). This variant is present in population databases (rs751589956, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with clinical features of TULP1-related conditions (PMID: 26047050, 31054281, 33781268). ClinVar contains an entry for this variant (Variation ID: 866967). For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV001075390 | SCV005072218 | pathogenic | Retinal dystrophy | 2018-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005036390 | SCV005669147 | pathogenic | Retinitis pigmentosa 14; Leber congenital amaurosis 15 | 2024-04-02 | criteria provided, single submitter | clinical testing | |
Laboratory of Genetics in Ophthalmology, |
RCV001255932 | SCV001432543 | pathogenic | Leber congenital amaurosis 15 | no assertion criteria provided | research |